Global Steroid Hormone API Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Steroid Hormone API Market Insights, Forecast to 2034
Steroid hormones, also known as steroid hormones, are a class of tetracyclic aliphatic hydrocarbon compounds with cyclopentane polyhydrophenanthrene nuclei. Steroid hormones are steroids that act as hormones. These include sex hormones for the gonads and corticosteroids for the adrenal cortex. Mammalian steroid hormones can be divided into five groups according to the steroid receptors they bindglucocorticoids, mineralocorticoids, androgens, estrogens, and progestogens.
Global Steroid Hormone API market is expected to reach to US$ 139 million in 2024, with a positive growth of %, compared with US$ 133 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Steroid Hormone API industry is evaluated to reach US$ 172.9 million in 2029. The CAGR will be 3.7% during 2024 to 2029.
Hormonal disorders, such as adrenal insufficiency, hypogonadism, and menopausal symptoms, are becoming more prevalent globally. Steroid hormones play a vital role in regulating various physiological functions, and their deficiency or imbalance can lead to health complications. The growing incidence of hormonal disorders is driving the demand for steroid hormone APIs to develop effective treatment options. Hormone replacement therapy is widely used to alleviate symptoms associated with menopause, such as hot flashes, vaginal dryness, and mood swings. Steroid hormone APIs, such as estrogen and progesterone, are key components of HRT formulations. With the aging population and increasing awareness about menopausal health, the demand for HRT and related steroid hormone APIs is expected to rise. The pharmaceutical industry is expanding worldwide, driven by factors such as population growth, increased healthcare spending, and advancements in healthcare infrastructure. Steroid hormone APIs are essential ingredients in the production of various pharmaceutical products, including oral tablets, injections, transdermal patches, and topical creams. The growth of the pharmaceutical industry fuels the demand for steroid hormone APIs. Steroidal drugs, such as corticosteroids, are widely used in the treatment of chronic inflammatory and autoimmune diseases, including asthma, rheumatoid arthritis, and inflammatory bowel disease. The effectiveness of these drugs in reducing inflammation and suppressing the immune system has led to their increased adoption. Consequently, the demand for steroid hormone APIs used in the manufacturing of steroidal drugs is growing. Advancements in manufacturing technologies have led to the production of high-quality steroid hormone APIs at a larger scale and lower costs. These advancements include improved purification techniques, novel synthesis methods, and the use of biotechnological processes. The technological progress in API manufacturing encourages the production of steroid hormone APIs and supports market growth. Regulatory approvals for new steroid hormone APIs and the expiration of patents for existing APIs play a significant role in the market. The introduction of new APIs allows the development of innovative pharmaceutical products, driving market growth. Additionally, the expiration of patents for certain steroid hormone APIs enables the entry of generic versions, fostering competition and potentially reducing prices. Pharmaceutical companies and research institutions are investing heavily in research and development activities related to hormonal therapies and steroid hormone APIs. This investment aims to discover new therapeutic applications, optimize drug delivery systems, and enhance the overall efficacy and safety profiles of steroid hormone-based medications. Such research and development initiatives contribute to the growth of the market.
Report Covers
This report presents an overview of global Steroid Hormone API market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Steroid Hormone API market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Zhejiang Xianju Pharmaceutical Co., Ltd.
Hubei Common Pharmaceutical Co., Ltd.
Hanjiang Pharmaceutical
Shandong Saito Biotechnology Co., Ltd.
Tianjin Tianyao Pharmaceutical Co., Ltd.
Xiaogan Danuo Technology Co., Ltd.
Hunan Xinhexin Biomedicine
Hunan Nuokai Biomedical Co., Ltd.
Kerui Corporation
Segment by Type
Natural
Semisynthetic
Pharmaceutical Factory
Biology Research
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Steroid Hormone API plant distribution, commercial date of Steroid Hormone API, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Steroid Hormone API introduction, etc. Steroid Hormone API Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Steroid Hormone API
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Steroid Hormone API market is expected to reach to US$ 139 million in 2024, with a positive growth of %, compared with US$ 133 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Steroid Hormone API industry is evaluated to reach US$ 172.9 million in 2029. The CAGR will be 3.7% during 2024 to 2029.
Hormonal disorders, such as adrenal insufficiency, hypogonadism, and menopausal symptoms, are becoming more prevalent globally. Steroid hormones play a vital role in regulating various physiological functions, and their deficiency or imbalance can lead to health complications. The growing incidence of hormonal disorders is driving the demand for steroid hormone APIs to develop effective treatment options. Hormone replacement therapy is widely used to alleviate symptoms associated with menopause, such as hot flashes, vaginal dryness, and mood swings. Steroid hormone APIs, such as estrogen and progesterone, are key components of HRT formulations. With the aging population and increasing awareness about menopausal health, the demand for HRT and related steroid hormone APIs is expected to rise. The pharmaceutical industry is expanding worldwide, driven by factors such as population growth, increased healthcare spending, and advancements in healthcare infrastructure. Steroid hormone APIs are essential ingredients in the production of various pharmaceutical products, including oral tablets, injections, transdermal patches, and topical creams. The growth of the pharmaceutical industry fuels the demand for steroid hormone APIs. Steroidal drugs, such as corticosteroids, are widely used in the treatment of chronic inflammatory and autoimmune diseases, including asthma, rheumatoid arthritis, and inflammatory bowel disease. The effectiveness of these drugs in reducing inflammation and suppressing the immune system has led to their increased adoption. Consequently, the demand for steroid hormone APIs used in the manufacturing of steroidal drugs is growing. Advancements in manufacturing technologies have led to the production of high-quality steroid hormone APIs at a larger scale and lower costs. These advancements include improved purification techniques, novel synthesis methods, and the use of biotechnological processes. The technological progress in API manufacturing encourages the production of steroid hormone APIs and supports market growth. Regulatory approvals for new steroid hormone APIs and the expiration of patents for existing APIs play a significant role in the market. The introduction of new APIs allows the development of innovative pharmaceutical products, driving market growth. Additionally, the expiration of patents for certain steroid hormone APIs enables the entry of generic versions, fostering competition and potentially reducing prices. Pharmaceutical companies and research institutions are investing heavily in research and development activities related to hormonal therapies and steroid hormone APIs. This investment aims to discover new therapeutic applications, optimize drug delivery systems, and enhance the overall efficacy and safety profiles of steroid hormone-based medications. Such research and development initiatives contribute to the growth of the market.
Report Covers
This report presents an overview of global Steroid Hormone API market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Steroid Hormone API market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Zhejiang Xianju Pharmaceutical Co., Ltd.
Hubei Common Pharmaceutical Co., Ltd.
Hanjiang Pharmaceutical
Shandong Saito Biotechnology Co., Ltd.
Tianjin Tianyao Pharmaceutical Co., Ltd.
Xiaogan Danuo Technology Co., Ltd.
Hunan Xinhexin Biomedicine
Hunan Nuokai Biomedical Co., Ltd.
Kerui Corporation
Segment by Type
Natural
Semisynthetic
Segment by Application
Pharmaceutical Factory
Biology Research
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Steroid Hormone API plant distribution, commercial date of Steroid Hormone API, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Steroid Hormone API introduction, etc. Steroid Hormone API Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Steroid Hormone API
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices